Randolph Noelle

Emeritus Professor of Microbiology and Immunology
Geisel School of Medicine at Dartmouth

Dr. Noelle is co-founder and Vice Chair of ImmuNext, and Professor of Immunology at the Geisel School of Medicine at Dartmouth. His laboratory discovered the natural CD40 ligand, CD154, and the checkpoint regulator, VISTA. ImmuNext's anti-CD40L antibody frexalimab is in Phase 3 trials at Sanofi. Dr. Noelle is in the top 5% of NIH funded scientists for total funding over his career and is a Fellow in the Academy of Medical Sciences.